IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity
International Journal of Inflammation · 2012
DOI: 10.1155/2012/156890 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Inflammation, 2012. Verfasst von Serena Colafrancesco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Viale del Policlinico 155, 00161 Roma, Italy. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Fondazione Umberto di Mario ONLUS.
Abstract (Originalsprache)
Introduction
Immunological factors seem to play a pivotal role in Adult Onset Still's Disease (AOSD). Among all, IL-18 cytokine is overexpressed and drives the inflammatory process.
Objective
We aimed to investigate the levels of IL-18 in sera of Italian patients with AOSD and to assess its possible role as a marker of disease activity.
Methods
IL-18 serum levels were determined by ELISA in 26 Italian patients with AOSD. Disease activity was assessed using Pouchot’s criteria. As controls, 21 patients with Rheumatoid Arthritis (RA), 21 patients with Sjogren's Syndrome (SS), 20 patients with Systemic Lupus Erythematosus (SLE), and 21 healthy subjects (normal human sera, NHS) were evaluated.
Results
IL-18 serum levels were significantly higher in patients with active AOSD than in non-active ( P = 0.001 ) and control groups (RA P = 0.0070 , SS P = 0.0029 , SLE P = 0.0032 , NHS P = 0.0004 ). A significant correlation between IL-18 serum levels and disease activity ( P < 0.0001 ), and laboratory parameters as ferritin ( P = 0.0127 ) and C-reactive protein ( P = 0.0032 ) was demonstrated.
Conclusions
Higher levels of IL-18 are detected in active AODS patients and correlate with disease activity and inflammatory laboratory features. ROC-AUC analysis of the serum concentration of IL-18 suggests that it can be considered a diagnostic marker of AOSD. This paper supports the targeting of this cytokine as a possible therapeutic option in AOSD.
Autor:innen und Institutionen
- Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Viale del Policlinico 155, 00161 Roma, Italy.
Förderung
- Fondazione Umberto di Mario ONLUS
Zitieren
APA
Colafrancesco, S., Priori, R., Alessandri, C., Perricone, C., Pendolino, M., Picarelli, G., & Valesini, G. (2012). IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity. International Journal of Inflammation. https://doi.org/10.1155/2012/156890
Vancouver
Colafrancesco S, Priori R, Alessandri C, Perricone C, Pendolino M, Picarelli G, et al. IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity. International Journal of Inflammation. 2012. doi:10.1155/2012/156890
BibTeX
@article{Colafrancesco2012,
author = {Colafrancesco, Serena and Priori, Roberta and Alessandri, Cristiano and Perricone, Carlo and Pendolino, Monica and Picarelli, Giovanna and Valesini, Guido},
title = {IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity},
journal = {International Journal of Inflammation},
year = {2012},
doi = {10.1155/2012/156890}
}
EUVIMED